| Name |
Format |
Description |
Link |
| Guidance on applications for drug clinical trials under the interim order: Additional requirements |
HTML |
|
https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/clinical-trials-interim-order-2-drug-guidance/additional-requirements.html |
| Guidance on applications for drug clinical trials under the interim order: Application guidelines and process |
HTML |
|
https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/clinical-trials-interim-order-2-drug-guidance/applications.html |
| Guidance on applications for drug clinical trials under the interim order: Who to contact |
HTML |
|
https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/clinical-trials-interim-order-2-drug-guidance/contact.html |
| Guidance on applications for drug clinical trials under the interim order: Overview |
HTML |
|
https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/clinical-trials-interim-order-2-drug-guidance.html |
| Guidance on applications for drug clinical trials under the interim order: Post-authorization requirements |
HTML |
|
https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/clinical-trials-interim-order-2-drug-guidance/post-authorization.html |
| Guidance on applications for drug clinical trials under the interim order: General requirements |
HTML |
|
https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/clinical-trials-interim-order-2-drug-guidance/requirements.html |
| Applications for COVID-19 drug and medical device clinical trials under the interim order: Notice of updated guidance documents |
HTML |
|
https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/covid19-industrie/medicaments-vaccins-traitements/essais-cliniques-arrete-urgence-2-medicaments-directrices/communiquer.html |
| Guidance on applications for drug clinical trials under the interim order: General requirements |
HTML |
|
https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/covid19-industrie/medicaments-vaccins-traitements/essais-cliniques-arrete-urgence-2-medicaments-directrices/exigences.html |
| Guidance on applications for drug clinical trials under the interim order: Additional requirements |
HTML |
|
https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/covid19-industrie/medicaments-vaccins-traitements/essais-cliniques-arrete-urgence-2-medicaments-directrices/exigences-supplementaires.htm |
| Guidance on applications for drug clinical trials under the interim order: Overview |
HTML |
|
https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/covid19-industrie/medicaments-vaccins-traitements/essais-cliniques-arrete-urgence-2-medicaments-directrices.html |
| Guidance on applications for drug clinical trials under the interim order: Post-authorization requirements |
HTML |
|
https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/covid19-industrie/medicaments-vaccins-traitements/essais-cliniques-arrete-urgence-2-medicaments-directrices/suite-autorisation.html |